Guangqian Xing

Guangqian Xing

Auto-generated profile, based on publicly available information

Guangqian Xing

Department of Otolaryngology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2007 in Cell Research
Verified
Journal Article
Closed access
GXGuangqian Xing
Guangqian Xing
ZCZhibin Chen
Zhibin Chen
XCXin Cao
Xin Cao

12 November 2014 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
QWQinjun Wei
Qinjun Wei
HZHongmei Zhu
Hongmei Zhu
XQXuli Qian
Xuli Qian
ZCZhibin Chen
Zhibin Chen
JYJun Yao
Jun Yao
GXGuangqian Xing
Guangqian Xing
Hereditary hearing loss is genetically heterogeneous, and hundreds of mutations in than 60 genes are involved in this disease. Therefore, it is difficult to identify the causative gene mutations involved. In this study, we combined targeted genomic capture and massively parallel sequencing (MPS) to address this issue. Using targeted genomic capture and MPS, 104 genes and three microRNA regions were selected and simultaneously sequenced in 23 unrelated probands of Chinese families with nonsyndromic hearing loss. The results were validated by Sanger sequencing for all available members of the probands' families. To analyze the possible pathogenic functional effects of the variants, three types of prediction programs (Mutation Taster, PROVEAN and SIFT) were used. A total of 195 healthy Chinese Han individuals were compared as controls to verify the novel causative mutations. Of the 23 probands, six had mutations in DFNA genes [WFS1 (n = 2), COCH, ACTG1, TMC1, and POU4F3] known to cause autosomal dominant nonsyndromic hearing loss. These included one novel in-frame indel mutation, three novel missense mutations and two reported missense mutations. Furthermore, one proband from a family with recessive DFNB carried two monoallelic mutations in the GJB2 and USH2A genes. All of these mutations co-segregated with the hearing loss phenotype in 36 affected individuals from 7 families and were predicted to be pathogenic. Mutations in uncommon deafness genes contribute to a portion of nonsyndromic deafness cases. In the future, critical gene mutations may be accurately and quickly identified in families with hereditary hearing loss by targeted genomic capture and MPS.

16 June 2006 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
GXGuangqian Xing
Guangqian Xing
ZCZhibin Chen
Zhibin Chen
QWQinjun Wei
Qinjun Wei
HTHuiqin Tian
Huiqin Tian
XLXiaolu Li
Xiaolu Li
XCXin Cao
Xin Cao

20 September 2015 in Chinese Medical Journal
Verified
Journal Article
Open access
PDF file
MLMei-Na Li-Yang
Mei-Na Li-Yang
XSXiaofei Shen
Xiaofei Shen
QWQin-Jun Wei
Qin-Jun Wei
JYJun Yao
Jun Yao
YLYajie Lu
Yajie Lu
GXGuang-Qian Xing
Guang-Qian Xing
Background: Nonsyndromic hearing loss (NSHL) is highly heterogeneous, in which more than 90 causative genes have currently been identified. DFNA5 is one of the deafness genes that known to cause autosomal dominant NSHL. Until date, only five DFNA5 mutations have been described in eight families worldwide. In this study, we reported the identification of a novel pathogenic mutation causing DFNA5 deafness in a five-generation Chinese family. Methods: After detailed clinical evaluations of this family, the genomic DNA of three affected individuals was selected for targeted exome sequencing of 101 known deafness genes, as well as mitochondrial DNA and microRNA regions. Co-segregation analysis between the hearing loss and the candidate variant was confirmed in available family members by direct polymerase chain reaction (PCR)-Sanger sequencing. Real-time PCR (RT-PCR) was performed to investigate the potential effect of the pathogenic mutation on messenger RNA splicing. Results: Clinical evaluations revealed a similar deafness phenotype in this family to that of previously reported DFNA5 families with autosomal dominant, late-onset hearing loss. Molecular analysis identified a novel splice site mutation in DFNA5 intron 8 (IVS8+1 delG). The mutation segregated with the hearing loss of the family and was absent in 120 unrelated control DNA samples of Chinese origin. RT-PCR showed skipping of exon 8 in the mutant transcript. Conclusions: We identified a novel DFNA5 mutation IVS8+1 delG in a Chinese family which led to skipping of exon 8. This is the sixth DFNA5 mutation relates to hearing loss and the second one in DFNA5 intron 8. Our findings provide further support to the hypothesis that the DFNA5-associated hearing loss represents a mechanism of gain-of-function.

22 February 2022 in JCI Insight
Verified
Journal Article
Open access
PDF file
HSHairong Shi
Hairong Shi
HWhongshun wang
hongshun wang
CZCheng Zhang
Cheng Zhang
YLYajie Lu
Yajie Lu
JYJun Yao
Jun Yao
XCXin Cao
Xin Cao
Defective primary cilia cause a range of diseases called ciliopathies, which include hearing loss (HL). Variants in the human oxysterol-binding protein like 2 (OSBPL2/ORP2) are responsible for autosomal dominant nonsyndromic HL (DFNA67). However, the pathogenesis of OSBPL2 deficiency has not been fully elucidated. In this study, we show that the Osbpl2 -KO mice exhibited progressive HL and abnormal cochlear development with defective cilia. Further research revealed that OSBPL2 was located at the base of the kinocilia in hair cells (HCs) and primary cilia in supporting cells (SCs) and functioned in the maintenance of ciliogenesis by regulating the homeostasis of PI(4,5)P 2 (phosphatidylinositol 4,5-bisphosphate) on the cilia membrane. OSBPL2 deficiency led to a significant increase of PI(4,5)P 2 on the cilia membrane, which could be partially rescued by the overexpression of INPP5E. In addition, smoothened and GL13, the key molecules in the Sonic Hedgehog (Shh) signaling pathway, were detected to be downregulated in Osbpl2 -KO HEI-OC1 cells. Our findings revealed that OSBPL2 deficiency resulted in ciliary defects and abnormal Shh signaling transduction in auditory cells, which helped to elucidate the underlying mechanism of OSBPL2 deficiency in HL.

28 September 2010 in The Journal of Laryngology & Otology
Verified
Journal Article
Closed access
PDF file
HZH Zhou
H Zhou
ZCZhiping Chen
Zhiping Chen
HLH Li
H Li
GXG Xing
G Xing
Objectives: To explore the pathology, diagnosis, therapeutic strategies and prognosis of primary temporal inverted papilloma.Methods: We present one of the first reported cases of primary temporal inverted papilloma with premalignant change. The available data are reviewed.Results: To the best of our knowledge, only 10 evaluable cases of this tumour have been reported. The recurrence rate is higher for this tumour than for sinonasal inverted papilloma.Conclusion: Primary temporal inverted papilloma is extremely rare, and its diagnosis should be made only following clinical exclusion of sinonasal papilloma. Therapy mainly comprises radical resection of the lesion, and long-term post-operative follow up is mandatory.